22.418 articles found

THIENOPYRIDINONE COMPOUNDS AND METHODS OF TREATMENT.

NOIMAN SILVIA, MARANTZ YAEL, MOHANTY PRADYUMNA, INBAL BOAZ, SHACHAM SHARON, DHANOA DALE S, BECKER OREN, WU LAURENCE, LOBERA MERCEDES.

· 2007-04-09

Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease

SCHENK DALE B, GAMES KCOTE D, BUTTINI MANUEL J, CHILCOTE TAMIE J, ROCKENSTEIN EDWARD, MASLIAH ELIEZAR.

· 2007-04-06

COMBINATION OF A CB1 RECEPTOR ANTAGONIST AND OF A PRODUCT WHICH ACTIVATES DOPAMINERGIC NEUROTRANSMISSION IN THE BRAIN, THE PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND THEIR USE IN THE TREATMENT OF PARKINSON'S DISEASE

BENAVIDES JESUS, BOCCIO DANIEL, HENIN YVETTE, PIOT-GROSJEAN ODILE.

· 2007-04-04

Prospects for gene therapy in inherited neurodegenerative diseases.

Cardone M.

Curr Opin Neurol · 2007-04-01

DOI: 10.1097/wco.0b013e32809f97ffPMID: 17351484

Duodenal levodopa infusion for the treatment of Parkinson's disease.

Samanta J, Hauser RA.

Expert Opin Pharmacother · 2007-04-01

DOI: 10.1517/14656566.8.5.657PMID: 17376020

Drug therapy for Parkinson's disease.

Hermanowicz N.

Semin Neurol · 2007-04-01

DOI: 10.1055/s-2007-971177PMID: 17390254

Safety and efficacy of newly formulated selegiline orally disintegrating tablets as an adjunct to levodopa in the management of 'off' episodes in patients with Parkinson's disease.

Lew MF, Pahwa R, Leehey M, Bertoni J, Kricorian G, Zydis Selegiline Study Group.

Curr Med Res Opin · 2007-04-01

DOI: 10.1185/030079906x167697PMID: 17407630

[Improvements in motor and non-motor symptoms in parkinson patients under ropinirole therapy].

Buchwald B, Angersbach D, Jost WH.

Fortschr Neurol Psychiatr · 2007-04-01

DOI: 10.1055/s-2007-959188PMID: 17427044

Unilateral intraputamenal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year of treatment and 1 year of withdrawal.

Slevin JT, Gash DM, Smith CD, Gerhardt GA, Kryscio R, Chebrolu H, Walton A, Wagner R, Young AB.

J Neurosurg · 2007-04-01

DOI: 10.3171/jns.2007.106.4.614PMID: 17432712

Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders.

Kenney C, Simpson R, Hunter C, Ondo W, Almaguer M, Davidson A, Jankovic J.

J Neurosurg · 2007-04-01

DOI: 10.3171/jns.2007.106.4.621PMID: 17432713

[Electroconvulsive therapy for neurological disorders].

Doi N, Sameshima T, Suwa H, Mera H, Nagao T, Yokochi M, Nakamura M, Isse K.

Brain Nerve · 2007-04-01

PMID: 17447517

[Gene therapy for Parkinson's disease].

Muramatsu S.

Brain Nerve · 2007-04-01

DOI: 10.1201/b15280-17PMID: 17447529